Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOE490 O (Glimepiride/Metformin) in T2DM
NCT00924573Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2009
- Primary completion
- Mar 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of glimepiride, liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started May 2009; status: completed.
02
Drugs
glimepirideliquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00924573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00924573.